AQP5 and colorectal cancer: Notably, our previous research has demonstrated that miR-185-3p enhances the chemosensitivity of colorectal cancer cells by targeting AQP5 [6], suggesting that AQP5 may serve as a regulatory target of miRNA-based therapeutics.